Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
Pete, a monthly column on St
PI3K/Akt/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumors
We still are going to move the dial
Lecture/other fees from Novo Nordisk, Sanofi, Lilly, Boehringer, Abbott
Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the SURPASS clinical trial programme
US$ 28.11
US$ 23.12
US$ 21.65
US$ 21.56
US$ 27.03
US$ 29.04
US$ 28.81
US$ 22.09
US$ 22.74
US$ 20.07
US$ 26.54
